Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 13 Pancreatic Neoplasms 10 Neoplasms 9 Ovarian Neoplasms 8 Neoplasm Metastasis 8 Squamous Cell Carcinoma of Head and Neck 6 Leukemia, Myeloid, Acute 6 Precursor Cell Lymphoblastic Leukemia-Lymphoma 5 Lung Neoplasms 5 Leukemia 5 Glioblastoma 5 Colorectal Neoplasms 5 Stomach Neoplasms 4 Neuroblastoma 4 Lymphoma, Non-Hodgkin 4 Lymphoma 4 Head and Neck Neoplasms 4 Fallopian Tube Neoplasms 4 Central Nervous System Neoplasms 4 Carcinoma, Ovarian Epithelial 4 Brain Neoplasms 4 Recurrence 3 Gliosarcoma 3 Esophageal Neoplasms 3 Breast Neoplasms 3 Astrocytoma 3 Advanced Solid Tumors 3 Unspecified Adult Solid Tumor, Protocol Specific 2 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2 Mesothelioma, Malignant 2

Interventions

genexol-PM 1 gadobutrol 1 Population Groups 1 NK Cell Lectin-Like Receptor Subfamily B 1 Exercise 1 Drug Therapy 1 Counseling 1 Cisplatin 1 AGuIX 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Gynecologic Cancer × Drug Therapy × Clear all

NCT03308604 2021-07-07

NANOCOL

Gustave Roussy, Cancer Campus, Grand Paris

Phase 1 Unknown

Gynecologic Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡